Gotham Asset Management’s Medicines Co MDCO Stock Holding History

Gotham Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,612	Closed	-$477K	–	1288
2019 Q4	$477K	Sell	5,612 -230	-4%	-$15.3K	0.01%	829
2019 Q3	$292K	Sell	5,842 -7,477	-56%	-$298K	0.01%	916
2019 Q2	$486K	Buy	+13,319	New	+$435K	0.01%	812
2014 Q4	–	Sell	-24,009	Closed	-$536K	–	1096
2014 Q3	$536K	Sell	24,009 -170,945	-88%	-$4.34M	0.01%	755
2014 Q2	$5.67M	Buy	+194,954	New	+$5.21M	0.07%	371
2014 Q1	–	Sell	-13,990	Closed	-$540K	–	1123
2013 Q4	$540K	Buy	+13,990	New	+$500K	0.01%	731

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Gotham Asset Management's MDCO Position: Q1 2020 in Review

Gotham Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 5,612 shares — an estimated $477K sold.

Gotham Asset Management first reported a position in MDCO in Q4 2013 and held it in 6 quarters. The position peaked at $5.67M in Q2 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Gotham Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Gotham Asset Management sold 5,612 Medicines Co shares in Q1 2020, an estimated $477K.
Gotham Asset Management first reported a position in Medicines Co in Q4 2013 and held it in 6 quarters.
Gotham Asset Management's Medicines Co position peaked at $5.67M in Q2 2014.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.